OFT condemns the Pharmaceutical Price Regulation Scheme

Price and Quantity Trends in the Pharmaceutical Benefits Scheme

Comparative approaches to pharmaceutical price regulation in the European Union.

AIM To review pharmaceutical price regulation methods in countries of the European Union (EU), in terms of the anticipated impact of regulation on pharmaceutical expenditures and evidence of actual outcomes. METHOD An extensive search was performed of medical and economic studies on regulatory interventions specifically targeting pharmaceutical prices in EU countries, published between Januar...

Price regulation in the pharmaceutical industry: prescription or placebo?

President Clinton and several Legislators have proposed restrictions on price increases in the pharmaceutical industry similar to those on some public utilities. Studies, however, suggest that under conditions of rapidly changing demand (as found in pharmaceuticals), price-caps could be manipulated. Using simulations, we show that in reaction to regulation, pharmaceutical firms would optimally ...

The Uk Pharmaceutical Price Regulation Scheme (Pprs) - Considerations of Voluntary Versus Statutory Regulations and How to Negotiate Pricing.

The UK operates free pricing of new chemical entities (NCEs) via the 2014 PPRS, which was a radical departure from its predecessors, focussing on industry’s obligation to repay the Department of Health (DH) for growth in the NHS drug expenditure beyond certain limits. These repayments currently exceed original estimates1,2, reducing certainty for members of the PPRS. The statutory regulations i...

Does Pharmaceutical Price Regulation Affect the Adoption of Generic Competition? Evidence from the OECD, 1999-2008

Generic competition in the pharmaceutical market is an effective cost-containment mechanism that improves static efficiency and stimulates pharmaceutical innovation. There is no prior study that has empirically analysed the relative delays in adoption of generic competition. This paper aims to investigate how price regulations in the OECD affect the adoption of generic competition following the...